Skip to main content
Frontiers in Nutrition logoLink to Frontiers in Nutrition
. 2026 Oct 23;13:1989162. doi: 10.3389/fnut.2026.1989162

Food consumption and combined dietary patterns in relation to Crohn’s disease: a case–control study in Saudi Arabia

Manal Malibary 1,2, Haytham A Sheerah 3,4,*, Ahmed Arafa 5, Mudi H Alharbi 6, Norah Eid Aljohani 6, Maryam M Alghamdi 6, Shoroog M Allogmanny 6, Amnah N Yamani 7, Mustafa M Shoqeair 8, Osama Z Alzeer 8, Haneen N Molla 8, Anas Almofarreh 9
PMCID: PMC13739521  PMID: 42996427

Abstract

Background

Dietary factors have been associated with Crohn’s disease (CD), but evidence regarding the role of combined dietary patterns remains limited. We investigated the associations of individual food consumption and broader dietary patterns with CD.

Methods

This case–control study included 219 patients with CD and 395 controls. Intake frequency of selected foods was scored on a four-level scale. Based on the combined consumption of foods classified as risk-promoting or protective, participants were grouped into four dietary patterns: high risk-promoting/low protective, high risk-promoting/high protective, low risk-promoting/low protective, and low risk-promoting/high protective. Associations with CD were assessed using multivariable logistic regression and expressed as odds ratios (ORs) with 95% confidence intervals (CIs).

Results

Patients with CD reported more frequent intakes of fast food, carbonated soft drinks, spicy food, and fruit: ORs (95% CIs) = 4.12 (3.02, 5.63), 3.89 (2.74, 5.52), 1.67 (1.33, 2.09), and 3.48 (2.41, 5.02), respectively. Participants with low consumption of risk-promoting foods had substantially lower CD odds, regardless of whether their consumption of protective foods was low (OR = 0.16, 95% CI: 0.07, 0.35) or high (OR = 0.14, 95% CI: 0.07, 0.27). High consumption of protective foods was not associated with lower CD odds when consumption of risk-promoting foods was also high (OR = 1.15, 95% CI: 0.69, 1.92).

Conclusion

Frequent intakes of fast food, carbonated soft drinks, and spicy food were associated with greater CD odds. Dietary patterns characterized by low consumption of risk-promoting foods were associated with substantially lower CD odds.

Keywords: Crohn’s disease, diet, dietary patterns, fast food, inflammatory bowel disease, soft drinks

Introduction

Crohn’s disease (CD) is a chronic inflammatory bowel disease (IBD) that can affect any part of the gastrointestinal tract and is characterized by periods of active disease and remission. Common manifestations of CD include abdominal pain, diarrhea, rectal bleeding, weight loss, and fatigue. CD frequently develops in young adults and may require prolonged medical treatment, repeated hospitalization, or surgery (1). Its long-term course can also impair physical and psychological well-being and quality of life and increase healthcare costs (1–4).

The epidemiology of CD has changed considerably over recent decades. While the disease has historically been concentrated in North America and Europe, its burden is increasing in regions where CD was previously less common (5, 6). This pattern is also evident in Arab populations. A systematic review from the Arab region estimated an annual CD incidence of approximately 1.46 per 100,000 persons and reported increasing rates of IBD over time (7). Rapid urbanization and socioeconomic development across the region have been accompanied by major changes in lifestyle, including a shift away from traditional diets toward more Westernized eating habits (8, 9).

The development of CD reflects interactions between genetic, immunological, microbial, and environmental factors (10, 11). Diet is of particular interest because, unlike genetic susceptibility, it can potentially be modified. Dietary exposures may affect intestinal inflammation through changes in the gut microbiota and the intestinal environment (12–14). Prospective evidence has linked inflammatory dietary patterns and greater consumption of Western and ultra-processed foods and carbonated beverages with a higher risk of CD (15–19), while higher fiber intake and greater adherence to Mediterranean or other healthy dietary patterns have been associated with lower risk (20–23). Increased consumption of processed foods, fast food, and sugar-sweetened beverages has become increasingly common in Arab countries as part of the ongoing nutrition transition (8, 9), making dietary factors particularly relevant to the study of CD in this population.

Using hospital-based data collected in Saudi Arabia, we previously examined several individual foods and beverages in relation to CD (24–28). These studies focused on specific dietary exposures. However, foods are consumed as part of broader dietary patterns rather than in isolation; therefore, evaluating them jointly may provide information beyond that obtained from individual-food analyses. In addition, previous analyses relied on grouped consumption categories, limiting assessment across the full range of intake frequency. Sex-specific associations were also not examined consistently, despite reported differences in environmental exposures and IBD susceptibility between men and women (29, 30).

The present study therefore extended these previous analyses by using the full ordinal consumption scale, evaluating combined dietary patterns, and conducting sex-stratified analyses. We assessed associations between individual food consumption scores and CD and examined dietary patterns based on joint levels of selected food groups.

Materials and methods

Study design, setting, and population

We conducted a hospital-based case–control study using clinical and questionnaire data from a private polyclinic in Riyadh, Saudi Arabia, between January 2009 and December 2017. Cases were adults aged ≥18 years with a new diagnosis of CD. Controls were adults attending the same clinic during the same period for gastrointestinal conditions other than IBD, primarily gastroenteritis (n = 344; 87.1% of controls), with smaller numbers diagnosed with gastroesophageal reflux disease, irritable bowel syndrome, hemorrhoids, or gallstone disease. Individuals with previous or current evidence of IBD, gastrointestinal malignancy, polyposis, or diverticulosis were not eligible as controls. Participants with incomplete dietary data were excluded as well.

Confirmation of Crohn’s disease

Patients with symptoms of IBD were initially assessed clinically and underwent urine and stool testing, complete blood count, and measurement of inflammatory markers. Those with findings suggestive of IBD proceeded to colonoscopy. Biopsy specimens collected during colonoscopy were evaluated histopathologically, and CD cases were included only when the diagnosis was supported by both colonoscopic and histopathological findings.

Dietary and covariate assessment

Dietary information was obtained using a self-administered questionnaire completed before the results of laboratory investigations, colonoscopy, and histopathological examination were available. Participants were asked to report their usual frequency of consuming fast food, carbonated soft drinks, spicy food, fruits, vegetables, dairy products, coffee, and tea during the period preceding the onset of their current gastrointestinal symptoms. Periods of fasting, including Ramadan, were excluded. For each food or beverage item, the response categories were monthly or less, weekly, twice weekly, and daily. The questionnaire assessed consumption frequency but did not collect information on portion size, total energy intake, number of meals, or nutrient intake. Therefore, the dietary variables represent frequency of consumption rather than quantitative intake. Information on age, sex, and smoking behavior was obtained from the questionnaire. Weight and height were measured at the clinic for body mass index (BMI) calculation. Laboratory measurements of inflammatory markers, including white blood cell (WBC), erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP), were obtained from medical records.

Statistical analysis

Continuous variables were summarized using means and standard deviations (SDs), while categorical variables were described using numbers and percentages. Differences between patients with CD and controls were tested using the independent-samples t-test for continuous variables and the chi-square test for categorical variables.

Dietary frequencies were coded from 1 to 4, with 1 representing monthly or less, 2 weekly, 3 twice weekly, and 4 daily consumptions. Each food score was analyzed as an ordinal variable, so the estimated OR represented the change in the odds of CD for a one-category increase in consumption frequency. Binary logistic regression was used to calculate odds ratios (ORs) and 95% confidence intervals (CIs). Model I included age and sex, Model II additionally included BMI and smoking, and Model III further included WBC, ESR, and CRP. As a sensitivity analysis, each dietary item was also dichotomized as daily versus non-daily consumption (twice weekly, weekly, or monthly or less). This dichotomization was used because some individual frequency categories contained few participants, resulting in sparse data and unstable estimates when all four categories were modeled separately. Effect modification by sex was formally assessed by including multiplicative interaction terms between sex and each dietary exposure in the regression models, and analyses were repeated separately for men and women, with adjustment for age, BMI, smoking, and inflammatory markers.

A risk-promoting dietary score was calculated as the mean of the four ordinal consumption scores for fast food, carbonated soft drinks, spicy food, and fruits. Similarly, a protective dietary score was calculated as the mean of the four ordinal consumption scores for vegetables, dairy products, coffee, and tea. Each food item was scored from 1 to 4, corresponding to monthly or less, weekly, twice weekly, and daily consumption, respectively. Therefore, both the risk-promoting and protective dietary scores ranged from 1 to 4. For each score, an average value of ≥3 was classified as high consumption, whereas a value <3 was classified as low consumption. The two classifications were then combined to generate four dietary patterns: high risk-promoting/low protective, high risk-promoting/high protective, low risk-promoting/low protective, and low risk-promoting/high protective.

All analyses were conducted using IBM SPSS Statistics for Windows, version 22.0 (IBM Corp., Armonk, NY, USA), and statistical significance was defined as a two-sided p-value < 0.05.

Results

Participant characteristics

The study included 219 patients with CD and 395 controls. Patients with CD were younger than controls (33.8 ± 7.8 vs. 37.6 ± 8.9 years, p-value < 0.001) and had a lower mean BMI (22.6 ± 4.7 vs. 27.2 ± 6.4 kg/m2, p-value < 0.001). Men represented 69.4% of the CD group and 64.8% of the control group, with no significant difference between the groups (p-value = 0.248). Smoking patterns were also similar (p-value = 0.219). Elevated counts of ESR (29.3% vs. 20.6%, p-value = 0.015) and CRP (20.9% vs. 13.6%, p-value = 0.018) were more common among patients with CD. Elevated WBC count was also more frequent in the CD group, although the difference was not statistically significant (4.2% vs. 1.7%, p-value = 0.082) (Table 1).

TABLE 1.

Sociodemographic and clinical characteristics of patients with Crohn’s disease and controls.

Characteristics Crohn’s disease n = 219 Control n = 395 P-value
Age (years), mean ± SD 33.8 ± 7.8 37.6 ± 8.9 <0.001
Sex, % Men 69.4 64.8 0.248
Women 30.6 35.2
Body mass index (kg/m2), mean ± SD 22.6 ± 4.7 27.2 ± 6.4 <0.001
Smoking, % No 79.9 79.3 0.219
<10 cig/day 3.2 1.0
10–20 cig/day 11.4 12.9
>20 cig/day 5.5 6.8
Elevated white blood cell, % 4.2 1.7 0.082
Elevated erythrocyte sedimentation rate, % 29.3 20.6 0.015
Elevated C-reactive protein, % 20.9 13.6 0.018

Dietary consumption

Patients with CD reported more frequent daily consumption of fast food (61.6% vs. 19.7%), carbonated soft drinks (65.8% vs. 24.8%), and spicy food (41.1% vs. 30.9%), as well as more frequent twice-weekly consumption of fruits (78.5% vs. 57.0%) (Figure 1). They also showed higher mean consumption scores for fast food (3.53 ± 0.67 vs. 2.61 ± 0.92, p-value < 0.001), carbonated soft drinks (3.61 ± 0.59 vs. 3.01 ± 0.74, p-value < 0.001), spicy food (3.17 ± 0.81 vs. 2.85 ± 0.87, p-value < 0.001), and fruits (3.08 ± 0.49 vs. 2.83 ± 0.66, p-value < 0.001). Mean consumption scores were lower among patients with CD for vegetables (3.49 ± 0.59 vs. 3.65 ± 0.50, p-value = 0.001), dairy products (3.67 ± 0.57 vs. 3.76 ± 0.43, p-value = 0.026), and coffee (3.21 ± 0.85 vs. 3.35 ± 0.80, p-value = 0.038), while tea consumption did not differ significantly (3.14 ± 0.83 vs. 3.27 ± 0.80, p-value = 0.052) (Figure 2 and Table 2).

FIGURE 1.

Clustered bar chart comparing daily, twice per week, weekly, and monthly or rarely consumption frequencies for fast food, soft drinks, spicy food, fruits, vegetables, dairy, coffee, and tea. Data categories include CD and control groups.

Dietary consumption frequencies among patients with Crohn’s disease and controls.

FIGURE 2.

Radar chart comparing mean consumption of eight food categories—fast food, soft drinks, spicy food, fruits, vegetables, dairy, coffee, and tea—between CD group (orange line) and control group (green line). CD group shows higher values across fast food, soft drinks, spicy food, and tea.

Mean dietary consumption scores among patients with Crohn’s disease and controls.

TABLE 2.

Dietary consumption scores among patients with Crohn’s disease and controls.

Food items Crohn’s disease mean ± SD Control mean ± SD P-value
Fast food 3.53 ± 0.67 2.61 ± 0.92 <0.001
Soft drinks 3.61 ± 0.59 3.01 ± 0.74 <0.001
Spicy food 3.17 ± 0.81 2.85 ± 0.87 <0.001
Fruits 3.08 ± 0.49 2.83 ± 0.66 <0.001
Vegetables 3.49 ± 0.59 3.65 ± 0.50 0.001
Dairy 3.67 ± 0.57 3.76 ± 0.43 0.026
Coffee 3.21 ± 0.85 3.35 ± 0.80 0.038
Tea 3.14 ± 0.83 3.27 ± 0.80 0.052

Association between individual dietary items and Crohn’s disease

Higher consumption of fast food, carbonated soft drinks, spicy food, and fruits was associated with higher odds of CD across all three models. In the fully adjusted model, each one-unit increase in the fast-food consumption score was associated with more than four-fold higher odds of CD (OR = 4.12, 95% CI: 3.02, 5.63), while the corresponding OR for carbonated soft drinks was 3.89 (95% CI = 2.74, 5.52). Higher spicy-food consumption was associated with 67% higher odds of CD (OR = 1.67, 95% CI: 1.33, 2.09), and higher fruit consumption was associated with more than three-fold higher odds (OR = 3.48, 95% CI: 2.41, 5.02). No significant associations were found for vegetables (OR = 0.85, 95% CI: 0.59, 1.22), dairy products (OR: 0.83, 95% CI: 0.56, 1.24), coffee (OR = 1.01, 95% CI: 0.80, 1.28), or tea (OR = 0.93, 95% CI: 0.73, 1.18) after full adjustment (Table 3).

TABLE 3.

Association between dietary consumption scores and Crohn’s disease.

Food items Model I OR (95% CI) Model II OR (95% CI) Model III OR (95% CI)
Fast food 3.94 (2.98, 5.22) 3.99 (2.97, 5.37) 4.12 (3.02, 5.63)
Soft drinks 3.68 (2.68, 5.06) 3.95 (2.82, 5.54) 3.89 (2.74, 5.52)
Spicy food 1.50 (1.22, 1.83) 1.61 (1.29, 1.99) 1.67 (1.33, 2.09)
Fruits 3.02 (2.18, 4.20) 3.15 (2.22, 4.46) 3.48 (2.41, 5.02)
Vegetables 0.78 (0.56, 1.08) 0.79 (0.56, 1.11) 0.85 (0.59, 1.22)
Dairy 0.87 (0.62, 1.24) 0.82 (0.56, 1.18) 0.83 (0.56, 1.24)
Coffee 0.87 (0.71, 1.07) 0.94 (0.75, 1.17) 1.01 (0.80, 1.28)
Tea 0.88 (0.70, 1.07) 0.90 (0.72, 1.13) 0.93 (0.73, 1.18)

Model I: adjusted for age and sex; Model II: further adjusted for BMI and smoking; Model III: further adjusted for inflammatory markers.

In sensitivity analyses comparing daily with non-daily consumption, daily consumption of fast food (OR = 6.16, 95% CI: 3.90, 9.72), carbonated soft drinks (OR: 5.38, 95% CI: 3.47, 8.32), spicy food (OR = 1.57, 95% CI: 1.05, 2.33), and fruits (OR: 1.72, 95% CI = 1.00, 2.98) was associated with higher odds of CD. No significant associations were observed for vegetables, dairy products, coffee, or tea (Supplementary Table 1).

Sex-stratified associations

Higher fast-food and carbonated soft-drink consumption was associated with CD in both men and women. For fast food, the adjusted OR was 3.79 (95% CI: 2.65, 5.43) in men and 5.45 (95% CI: 2.81, 10.57) in women, while the corresponding ORs for carbonated soft drinks were 4.31 (95% CI: 2.80, 6.61) and 3.06 (95% CI: 1.60, 5.82), respectively. Higher fruit consumption was also associated with CD in both men (OR = 3.76, 95% CI: 2.42, 5.84) and women (OR = 3.16, 95% CI: 1.52, 6.57). Higher spicy-food consumption was associated with CD among men (OR = 1.77, 95% CI: 1.35, 2.32), while the estimate among women was less precise (OR = 1.49, 95% CI: 0.97, 2.29). However, there was no evidence of effect modification by sex (p-value for interaction > 0.10). No significant associations were found for vegetables, dairy products, coffee, or tea in either sex (Table 4). In sensitivity analyses comparing daily with non-daily consumption, the sex-stratified sensitivity analyses showed broadly similar patterns (Supplementary Table 1).

TABLE 4.

Sex-stratified associations between dietary consumption scores and Crohn’s disease.

Food items Men OR (95% CI) Women OR (95% CI)
Fast food 3.79 (2.65, 5.43) 5.45 (2.81, 10.57)
Soft drinks 4.31 (2.80, 6.61) 3.06 (1.60, 5.82)
Spicy food 1.77 (1.35, 2.32) 1.49 (0.97, 2.29)
Fruits 3.76 (2.42, 5.84) 3.16 (1.52, 6.57)
Vegetables 0.79 (0.56, 1.11) 1.01 (0.66, 1.55)
Dairy 0.81 (0.50, 1.30) 1.04 (0.49, 2.19)
Coffee 0.90 (0.67, 1.19) 1.39 (0.89, 2.17)
Tea 1.05 (0.79, 1.41) 0.74 (0.47, 1.18)

ORs are adjusted for age, BMI, smoking, and inflammatory markers.

Dietary patterns and Crohn’s disease

The high risk-promoting/low protective dietary pattern was more common among patients with CD than controls (36.5% vs. 17.2%), as was the high risk-promoting/high protective pattern (50.2% vs. 30.4%). In contrast, the low risk-promoting/low protective pattern was less common among patients with CD (4.6% vs. 15.9%), as was the low risk-promoting/high protective pattern (8.7% vs. 36.5%) (Figure 3). Compared with the high risk-promoting/low protective pattern, the low risk-promoting/low protective pattern was associated with substantially lower odds of CD after full adjustment (OR = 0.16, 95% CI: 0.07, 0.35), and a similar association was observed for the low risk-promoting/high protective pattern (OR = 0.14, 95% CI: 0.07, 0.27). The high risk-promoting/high protective pattern was not significantly associated with CD compared with the reference pattern (OR = 1.15, 95% CI = 0.69, 1.92) (Table 5).

FIGURE 3.

Stacked bar chart compares Control and CD groups by four risk-protective categories. Control: 17.2% high risk–low protective, 30.4% high risk–high protective, 15.9% low risk–low protective, 36.5% low risk–high protective. CD: 36.5% high risk–low protective, 50.2% high risk–high protective, 4.6% low risk–low protective, 8.7% low risk–high protective. Category colors and numeric percentages are shown within the bars.

Distribution of combined dietary patterns among patients with Crohn’s disease and controls.

TABLE 5.

Association between combined dietary patterns and Crohn’s disease.

Dietary patterns Model I OR (95% CI) Model II OR (95% CI) Model III OR (95% CI)
High risk-promoting/low protective Ref Ref Ref
High risk-promoting/high protective 0.89 (0.57, 1.39) 1.02 (0.63, 1.65) 1.15 (0.69, 1.92)
Low risk-promoting/low protective 0.16 (0.07, 0.34) 0.14 (0.07, 0.32) 0.16 (0.07, 0.35)
Low risk-promoting/high protective 0.14 (0.08, 0.27) 0.14 (0.07, 0.27) 0.14 (0.07, 0.27)

Model I: adjusted for age and sex; Model II: further adjusted for BMI and smoking; Model III: further adjusted for inflammatory markers.

Discussion

The present study aimed to evaluate associations between individual food consumptions and CD, examine combined dietary patterns, and explore potential sex-specific differences. In line with these aims, fast food, carbonated soft drinks, spicy food, and fruit were positively associated with CD, with generally similar findings in men and women. Most importantly, dietary patterns characterized by low consumption of risk-promoting foods were associated with substantially lower odds of CD, irrespective of the level of protective food consumption.

The associations with fast food and carbonated soft drinks are consistent with evidence linking Western and highly processed diets with CD. A meta-analysis of pre-illness dietary patterns found that a Western dietary pattern was associated with higher CD risk (16), while a large prospective study of 245,112 participants reported a 70% higher risk of CD among those in the highest versus lowest quartile of ultra-processed food consumption (18). A meta-analysis of beverage studies also reported a positive association between soft-drink consumption and CD (19). Fast foods and sugar-sweetened beverages may represent several correlated exposures, including refined carbohydrates, added sugars, fats, and food additives. These dietary characteristics may influence intestinal inflammation through changes in immune responses, metabolic pathways, gut microbial composition, and intestinal barrier function (31, 32). The association with spicy food was weaker than those observed for fast food and soft drinks, and the epidemiological evidence for spicy food and incident CD remains limited. Experimental studies indicate that capsaicin can affect TRPV1 signaling, intestinal permeability, and gut microbial composition, although these effects appear to depend on dose and experimental conditions (33, 34). The finding should therefore be interpreted cautiously and does not establish a direct harmful effect of spicy food.

Participants with low risk-promoting consumption had substantially lower odds of CD whether their protective-food consumption was low or high, whereas high protective-food consumption was not associated with lower odds when risk-promoting consumption remained high. This differs from prospective studies in which greater adherence to Mediterranean or other healthy dietary patterns was associated with lower CD risk (22, 23). A recent meta-analysis similarly reported approximately 41% and 30% lower CD risk with Mediterranean and healthy dietary patterns, respectively (35). However, these established dietary patterns incorporate a wider range of foods and dietary characteristics than the protective-food score used in the present study. Our findings therefore suggest that, within the limited set of foods assessed here, lower consumption of risk-promoting foods may have been more strongly associated with CD than higher consumption of the foods classified as protective.

The positive association with fruit was the main finding that differed from the broader literature. Earlier prospective evidence generally suggested an inverse association between fruit consumption and CD (20), whereas the recent meta-analysis found no overall association for combined fruit and vegetable intake, despite a clear inverse association with dietary fiber (35). Most patients with CD were concentrated in the twice-weekly fruit category rather than the daily category, suggesting that the relationship may not follow a simple linear gradient. The positive association with fruit should be considered exploratory and requires confirmation in prospective studies where diet is measured before symptom onset.

The absence of significant associations with vegetables, dairy products, coffee, and tea is also consistent with the variable findings reported for individual foods. Earlier meta-analyses suggested inverse associations of vegetables and dairy products with CD (20, 25), but the more recent synthesis restricted to prospective studies found no significant overall association for vegetables or dairy products (35). Similarly, the available beverage meta-analysis found no association for coffee and an inverse association for tea (19). Taken together, the evidence for individual foods appears less consistent than that for broader dietary patterns or food processing. This may partly reflect differences in dietary assessment, portion size, food preparation, background diet, and the correlations between foods consumed within the same dietary pattern.

The sex-stratified analyses did not suggest major differences between men and women. Fast food, carbonated soft drinks, and fruit were associated with CD in both sexes. Nevertheless, sex-related differences in IBD susceptibility and environmental exposures have been described (29, 30), but prospective evidence for sex-specific dietary associations remains limited. In the Swedish Mediterranean diet cohorts, for example, the association with CD was not modified by sex (22). However, in our recent study from the same dataset, spicy food was positively associated with ulcerative colitis in men, while vegetable consumption in women and dairy consumption in men were inversely associated with ulcerative colitis (36).

Several features strengthen this study. First, CD diagnoses were supported by colonoscopy and histopathology, reducing the possibility of outcome misclassification. Second, dietary information was collected before participants were informed of a confirmed diagnosis, and the use of four consumption categories retained more information than a simple high-versus-low classification. Third, the combined dietary analysis also extends the earlier food-specific analyses by considering selected foods jointly.

The findings should nevertheless be interpreted in light of several limitations. First, the case–control design and retrospective dietary assessment limit inference about temporality. Although participants were asked to report their usual dietary consumption before the onset of gastrointestinal symptoms, dietary information was collected after symptoms had developed; therefore, recall bias and reverse causation cannot be excluded. Second, the use of patients with gastrointestinal disorders as controls may have introduced selection bias, as their symptoms may also have influenced dietary behavior. Third, dietary assessment was limited to consumption frequency and did not include portion size, total energy intake, nutrient composition, or the complete diet. In addition, the questionnaire was not formally validated and its reliability was not assessed, which may have introduced measurement error. Fourth, treating the four frequency categories as an ordinal score assumes a similar change in log odds between consecutive categories, which may not be appropriate for every food. Sensitivity analyses comparing daily with non-daily consumption were therefore performed, although this approach may reduce information on intermediate consumption frequencies. Fifth, the dietary patterns were constructed from the limited dietary variables available in this dataset, and the classification of foods as risk-promoting or protective was based partly on evidence from the same source population. These patterns should therefore be considered operational rather than established dietary indices and require validation in independent populations. Sixth, residual confounding remains possible because information on several potentially relevant dietary, socioeconomic, and lifestyle factors was unavailable. Inflammatory markers were also measured around the time of diagnosis and may themselves have been influenced by active or preclinical CD. Seventh, multiple dietary exposures and sex-stratified analyses were examined without formal correction for multiple comparisons, so some findings, particularly subgroup findings, may have occurred by chance. Eighth, recruitment from a single private clinic in Riyadh and the use of data collected between 2009 and 2017 may limit generalizability to the broader Saudi and Arab populations and to current dietary patterns.

Conclusion

Frequent consumption of fast food, carbonated soft drinks, and spicy food was associated with higher odds of CD, while dietary patterns characterized by low consumption of risk-promoting foods were associated with markedly lower odds, regardless of protective-food consumption. Given the retrospective assessment of diet, these findings should not be interpreted as evidence of a causal relationship. Prospective studies are needed to confirm these associations and examine potential biological explanations.

Acknowledgments

We thank all participants and staff.

Funding Statement

The author(s) declared that financial support was received for this work and/or its publication. The authors gratefully acknowledge the Deanship of Scientific Research (DSR) at King Abdulaziz University, Jeddah, Saudi Arabia, for funding this research under grant number (IPP: 1391-253-2026).

Footnotes

Edited by: Zumin Shi, Qatar University, Qatar

Reviewed by: Haiyang Wang, Anhui Normal University, China

Nasib Al Shibli, Aljouf Health Cluster, Saudi Arabia

Data availability statement

We did not make our data publicly available due to ethical or administrative reasons. Requests to access the datasets should be directed to HS, haytham.sheerah@live.com.

Ethics statement

The Institutional Review Board (IRB) of the King Fahd Medical City approved the study protocol (IRB registration number: H-01-R-012; approval date: 18/10/2018). The study was conducted per the Declaration of Helsinki. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.

Author contributions

MM: Writing – original draft, Writing – review & editing, Funding acquisition, Software, Investigation, Data curation, Resources, Formal analysis, Conceptualization, Project administration, Visualization, Validation, Methodology. AA: Resources, Writing – review & editing. MA: Writing – review & editing, Resources. NA: Resources, Writing – review & editing. MMA: Resources, Writing – review & editing. SA: Writing – review & editing, Resources. AY: Resources, Writing – review & editing. MS: Writing – review & editing, Resources. OA: Resources, Writing – review & editing. HM: Writing – review & editing, Resources. AAl: Resources, Writing – review & editing. HS: Writing – original draft, Writing – review & editing, Funding acquisition, Software, Investigation, Data curation, Resources, Formal analysis, Conceptualization, Project administration, Visualization, Validation, Methodology, Supervision.

Conflict of interest

The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Generative AI statement

The author(s) declared that Generative AI was not used in the creation of this manuscript.

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fnut.2026.1989162/full#supplementary-material

Table_1.docx (25.3KB, docx)

References

  • 1.Fakhoury M, Negrulj R, Mooranian A, Al-Salami H. Inflammatory bowel disease: clinical aspects and treatments. J Inflamm Res. (2014) 7:113–20. 10.2147/JIR.S65979 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Gasche C. Complications of inflammatory bowel disease. Hepatogastroenterology. (2000) 47:49–56. [PubMed] [Google Scholar]
  • 3.Caballero-Mateos AM. Gut feelings: the psychological impact of inflammatory bowel disease. J Clin Med. (2023) 12:3867. 10.3390/jcm12123867 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Lichtenstein GR, Shahabi A, Seabury SA, Lakdawalla DN, Espinosa OD, Green S, et al. Lifetime economic burden of crohn’s disease and ulcerative colitis by age at diagnosis. Clin Gastroenterol Hepatol. (2020) 18:889–97.e10. 10.1016/j.cgh.2019.07.022 [DOI] [PubMed] [Google Scholar]
  • 5.Wang R, Li Z, Liu S, Zhang D. Global, regional and national burden of inflammatory bowel disease in 204 countries and territories from 1990 to 2019: a systematic analysis based on the Global Burden of Disease Study 2019. BMJ Open. (2023) 13:e065186. 10.1136/bmjopen-2022-065186 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Alsakarneh S, Ahmed M, Jaber F, Abuassi M, Mourad FH, Francis FF, et al. Inflammatory bowel disease burden in the Middle East and North Africa Region: a comprehensive analysis of incidence, prevalence, and mortality from 1990–2019. Ann Gastroenterol. (2024) 37:527–35. 10.20524/aog.2024.0909 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Mosli M, Alawadhi S, Hasan F, Abou Rached A, Sanai F, Danese S. Incidence, prevalence, and clinical epidemiology of inflammatory bowel disease in the arab world: a systematic review and meta-analysis. Inflamm Intest Dis. (2021) 6:123–31. 10.1159/000518003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Aboul-Enein BH, Bernstein J, Neary AC. Dietary transition and obesity in selected Arabicspeaking countries: a review of the current evidence. East Mediterr Health J. (2016) 22:763–70. 10.26719/2016.22.10.763 [DOI] [PubMed] [Google Scholar]
  • 9.Basha H, Shalash A, Wahdan Y, Abu-Rmeileh NME. Shifts in food consumption patterns in the Levant: a systematic review of the last six decades. Int J Behav Nutr Phys Act. (2025) 22:50. 10.1186/s12966-025-01741-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Wu T, Cheng H, Zhuang J, Liu X, Ouyang Z, Qian R. Risk factors for inflammatory bowel disease: an umbrella review. Front Cell Infect Microbiol. (2025) 14:1410506. 10.3389/fcimb.2024.1410506 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Yang X, Guo H, Zou M. Inflammatory bowel diseases: pathological mechanisms and therapeutic perspectives. Mol Biomed. (2026) 7:2. 10.1186/s43556-025-00395-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.He K, Qin Y, Li B, Ye H, Li C, Qi K, et al. Dietary patterns and inflammatory bowel disease: a global assessment of eight nutrients by region, gender, and socioeconomic status. Front Nutr. (2025) 12:1570634. 10.3389/fnut.2025.1570634 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Anneberg OM, Petersen ISB, Jess T, De Freitas MB, Jalili M. The dietary inflammatory potential and its role in the risk and progression of inflammatory bowel disease: a systematic review. Clin Nutr. (2025) 47:146–56. 10.1016/j.clnu.2025.02.019 [DOI] [PubMed] [Google Scholar]
  • 14.Knight-Sepulveda K, Kais S, Santaolalla R, Abreu MT. Diet and inflammatory bowel disease. Gastroenterol Hepatol. (2015) 11:511–20. [PMC free article] [PubMed] [Google Scholar]
  • 15.Lo CH, Lochhead P, Khalili H, Song M, Tabung FK, Burke KE, et al. Dietary inflammatory potential and risk of crohn’s disease and ulcerative colitis. Gastroenterology. (2020) 159:873–83.e1. 10.1053/j.gastro.2020.05.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Li T, Qiu Y, Yang HS, Li MY, Zhuang XJ, Zhang SH, et al. Systematic review and meta-analysis: association of a pre-illness Western dietary pattern with the risk of developing inflammatory bowel disease. J Dig Dis. (2020) 21:362–71. 10.1111/1751-2980.12910 [DOI] [PubMed] [Google Scholar]
  • 17.Rizzello F, Spisni E, Giovanardi E, Imbesi V, Salice M, Alvisi P, et al. Implications of the westernized diet in the onset and progression of IBD. Nutrients. (2019) 11:1033. 10.3390/nu11051033 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Lo CH, Khandpur N, Rossato SL, Lochhead P, Lopes EW, Burke KE, et al. Ultra-processed foods and risk of Crohn’s disease and ulcerative colitis: a prospective cohort study. Clin Gastroenterol Hepatol. (2022) 20:e1323–37. 10.1016/j.cgh.2021.08.031 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Yang Y, Xiang L, He J. Beverage intake and risk of Crohn disease: a meta-analysis of 16 epidemiological studies. Medicine. (2019) 98:e15795. 10.1097/MD.0000000000015795 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Milajerdi A, Ebrahimi-Daryani N, Dieleman LA, Larijani B, Esmaillzadeh A. Association of dietary fiber, fruit, and vegetable consumption with risk of inflammatory bowel disease: a systematic review and meta-analysis. Adv Nutr. (2021) 12:735–43. 10.1093/advances/nmaa145 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Deng M, Dan L, Ye S, Chen X, Fu T, Wang X, et al. Higher dietary fibre intake is associated with lower risk of inflammatory bowel disease: prospective cohort study. Alimentary Pharmacol Therapeutics. (2023) 58:516–25. 10.1111/apt.17649 [DOI] [PubMed] [Google Scholar]
  • 22.Khalili H, Håkansson N, Chan SS, Chen Y, Lochhead P, Ludvigsson JF, et al. Adherence to a Mediterranean diet is associated with a lower risk of later-onset Crohn’s disease: results from two large prospective cohort studies. Gut. (2020) 69:1637–44. 10.1136/gutjnl-2019-319505 [DOI] [PubMed] [Google Scholar]
  • 23.Xia B, Li Y, Hu L, Xie P, Mi N, Lv L, et al. Healthy eating patterns associated with reduced risk of inflammatory bowel disease by lowering low-grade inflammation: evidence from a large prospective cohort study. BMC Med. (2024) 22:589. 10.1186/s12916-024-03809-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Almofarreh A, Sheerah HA, Arafa A, Alzeer O, Alohali E, Cao J, et al. Association between coffee, tea, and soft drinks consumption and Crohn’s disease in Arab populations: a case-control study. Clin Nutr Open Sci. (2024) 55:116–22. 10.1016/j.nutos.2024.03.012 [DOI] [Google Scholar]
  • 25.Almofarreh AM, Sheerah HA, Arafa A, Al Mubarak AS, Ali AM, Al-Otaibi NM, et al. Dairy consumption and inflammatory bowel disease among arab adults: a case-control study and meta-analysis. Nutrients. (2024) 16:2747. 10.3390/nu16162747 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Almofarreh AM, Sheerah HA, Arafa A, Algori FA, Almutairi GR, Alenzi KA, et al. Fruit and vegetable consumption and inflammatory bowel disease: a case-control study. Life. (2024) 14:1524. 10.3390/life14121524 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Almofarreh A, Sheerah HA, Arafa A, AlBassam AM, Alassaf MA, AlBassam FM, et al. The association between fast food consumption and inflammatory bowel disease: a case-control study and meta-analysis. Nutrients. (2025) 17:1838. 10.3390/nu17111838 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Almofarreh A, Sheerah HA, Arafa A, Moh’d T, Tayyib RA, Yamani AN, et al. Association between spicy food consumption and inflammatory bowel disease: a case-control study from Saudi Arabia. Nutrition. (2026) 145:113087. 10.1016/j.nut.2025.113087 [DOI] [PubMed] [Google Scholar]
  • 29.Goodman WA, Erkkila IP, Pizarro TT. Sex matters: impact on pathogenesis, presentation and treatment of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. (2020) 17:740–54. 10.1038/s41575-020-0354-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Rustgi SD, Kayal M, Shah SC. Sex-based differences in inflammatory bowel diseases: a review. Ther Adv Gastroenterol. (2020) 13:1756284820915043. 10.1177/1756284820915043 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Myles IA. Fast food fever: reviewing the impacts of the Western diet on immunity. Nutr J. (2014) 13:61. 10.1186/1475-2891-13-61 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.O’Connor L, Imamura F, Brage S, Griffin SJ, Wareham NJ, Forouhi NG. Intakes and sources of dietary sugars and their association with metabolic and inflammatory markers. Clin Nutr. (2018) 37:1313–22. 10.1016/j.clnu.2017.05.030 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Xiang Q, Tang X, Cui S, Zhang Q, Liu X, Zhao J, et al. Capsaicin, the spicy ingredient of chili peppers: effects on gastrointestinal tract and composition of gut microbiota at various dosages. Foods. (2022) 11:686. 10.3390/foods11050686 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Zhang X, Hu H, Zhang Y, Hu S, Lu J, Peng W, et al. Dietary capsaicin exacerbates gut microbiota dysbiosis and mental disorders in type 1 diabetes mice. Nutrients. (2025) 17:593. 10.3390/nu17030593 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Meyer A, Agrawal M, Savin-Shalom E, Wong ECL, Levinson C, Gold S, et al. Impact of diet on inflammatory bowel disease risk: systematic review, meta-analyses and implications for prevention. EClinicalMedicine. (2025) 86:103353. 10.1016/j.eclinm.2025.103353 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Sheerah HA, Arafa A, Jalloun RA, Alharbi MH, Molla HN, Yamani AN, et al. Association of dietary components and combined dietary profiles with ulcerative colitis: a case-control study. Diseases. (2026) 14:297. 10.3390/diseases14080297 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Table_1.docx (25.3KB, docx)

Data Availability Statement

We did not make our data publicly available due to ethical or administrative reasons. Requests to access the datasets should be directed to HS, haytham.sheerah@live.com.


Articles from Frontiers in Nutrition are provided here courtesy of Frontiers Media SA

RESOURCES